​
​

Pliant Therapeutics (PLRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Pliant Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.58M

0

Pliant Therapeutics Revenue by Period

Pliant Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$1.58M-83.69%
2022-12-31$9.69M27.91%
2021-12-31$7.57M-81.89%
2020-12-31$41.82M-26.70%
2019-12-31$57.05M100.00%
2018-12-31--

Pliant Therapeutics generated $1.58M in revenue during NA 2023, up -83.69% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Pliant Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$4.84M100.00%
2023-09-30--100.00%
2023-06-30$248.00K-81.38%
2023-03-31$1.33M-32.21%
2022-12-31$1.97M32.59%
2022-09-30$1.48M-70.29%
2022-06-30$4.99M299.44%
2022-03-31$1.25M-37.52%
2021-12-31$2.00M24.16%
2021-09-30$1.61M-10.01%
2021-06-30$1.79M-17.71%
2021-03-31$2.17M-51.31%
2020-12-31$4.46M-7.25%
2020-09-30$4.81M33.72%
2020-06-30$3.60M-87.56%
2020-03-31$28.94M-49.28%
2019-12-31$57.05M100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-03-31--

Pliant Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Pliant Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACLXArcellx$110.32M$26.03M
ARVNArvinas$78.50M$102.40M
RLAYRelay Therapeutics$25.55M-
RVMDRevolution Medicines, Inc. Warrant$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
CYTKCytokinetics$7.53M$463.00K
PLRXPliant Therapeutics$1.58M-
BCELAtreca$770.00K$80.00K
VRDNViridian Therapeutics$314.00K$86.00K
BDTXBlack Diamond Therapeutics--
INZYInozyme Pharma--
DYNDyne Therapeutics--
MDGLMadrigal Pharmaceuticals-$62.17M
PASGPassage Bio--
SNDXSyndax Pharmaceuticals-$12.50M
ETNB89bio--

PLRX Revenue FAQ

What is Pliant Therapeutics’s yearly revenue?

Pliant Therapeutics's yearly revenue for 2023 was $1.58M, representing a decrease of -83.69% compared to 2022. The company's yearly revenue for 2022 was $9.68M, representing an increase of 27.91% compared to 2021. PLRX's yearly revenue for 2021 was $7.57M, representing a decrease of -81.89% compared to 2020.

What is Pliant Therapeutics’s quarterly revenue?

Pliant Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). PLRX's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Pliant Therapeutics’s revenue growth rate?

Pliant Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -79.13%, and for the last 5 years (2019-2023) was -97.23%.